Tenecteplase is a medication used to dissolve blood clots. It's a type of medicine called a fibrinolytic, which helps break down clots that can block blood flow. It's often used in emergencies, like after a heart attack, to help restore blood flow to the heart muscle.
Every report comes from a Lived member, sent anonymously.
Have you tried Tenecteplase for Anterior Cerebral Artery Stroke?
Tenecteplase, sold in the US as TNKase (and as Metalyse in Europe), is an emergency clot-dissolving medicine. In the US it is approved for adults having an ischemic stroke, the kind caused by a clot blocking blood flow to part of the brain, and to reduce the risk of death in adults having a STEMI (ST-elevation myocardial infarction), a major heart attack in which a coronary artery is fully blocked, named for a pattern on the heart tracing. It is one of a group of drugs called thrombolytics, or clot busters. For stroke, it is an alternative to the older standard, alteplase (Activase). For a heart attack, many hospitals instead open the artery with a catheter procedure called angioplasty; tenecteplase is used when that cannot happen quickly, and the two are not routinely combined.
Blood clots are held together by a protein mesh called fibrin. The body breaks this mesh down with an enzyme, plasmin. Tenecteplase is a modified version of tissue plasminogen activator (tPA), the natural protein that switches plasmin on. It attaches to fibrin in the clot and activates plasmin there, so the clot dissolves and blood can flow again. The sooner flow returns, the more brain or heart tissue can be saved.
Tenecteplase is given only in hospital, as a single injection into a vein over about 5 seconds. The dose is based on body weight, and the stroke dose is about half the heart attack dose. Unlike alteplase, it needs no hour-long infusion afterward. It only helps if given early. For stroke, the US label calls for treatment within 3 hours of when symptoms began, after a brain scan rules out bleeding. Knowing when symptoms started, or when the person was last seen well, is one of the most useful things a family member can tell the team.
Bleeding is the main side effect. It often shows up as oozing or bruising where needles or catheters went in. The serious risk is bleeding inside the body, including in the brain, which can be fatal. In the main stroke trial, about 3 in 100 people had a brain bleed that worsened their condition, similar to alteplase. Allergic reactions, including swelling of the lips or tongue, are uncommon. During a heart attack, irregular heart rhythms can appear as blood flow returns, and the team is ready to treat them. Bleeding can also appear a day or more later, especially on blood thinners. After leaving the hospital, call 911 for a severe headache, new weakness or numbness on one side, confusion, vomiting blood or blood in urine or stool.
Tenecteplase is not given to people with active internal bleeding, a known bleeding disorder, severe uncontrolled high blood pressure, brain or spine surgery or serious head injury in the past two months, or a brain tumor, aneurysm or abnormal tangle of blood vessels. Recent major surgery, recent stomach or urinary bleeding, pregnancy and older age raise the risk and are weighed against the benefit. Medicines that slow clotting add to bleeding risk, including anticoagulants such as warfarin or apixaban (Eliquis) and antiplatelet drugs such as aspirin or clopidogrel. Telling the team about them, or bringing a medication list, can change the decision.
Treatment is followed by close monitoring in hospital, with frequent checks of blood pressure, alertness and strength. After a stroke caused by a large blocked artery, some people also have a procedure to pull the clot out. After a heart attack, a catheter procedure may still follow if the artery needs more work. Results vary. In the main stroke trial, just over a third of people treated had little or no disability three months later, similar to alteplase. Tenecteplase is a one-time treatment; recovery then depends on rehabilitation and on long-term medicines that lower the chance of another clot.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Tenecteplase, what you've noticed, or ask the community a question.